Showing 1 - 10 results of 10 for search 'Cheng Cui', query time: 0.08s Refine Results
  1. 1
    PEGylated exenatide injection (PB-119) improves beta-cell function and insulin resistance in treatment-naïve type 2 diabetes mellitus patients

    PEGylated exenatide injection (PB-119) improves beta-cell function and insulin resistance in treatment-naïve type 2 diabetes mellitus patients by Xu Liu, Xu Liu, Xu Liu, Ling Song, Ling Song, Ling Song, Yuanhui Zhang, Haiyan Li, Haiyan Li, Haiyan Li, Cheng Cui, Cheng Cui, Cheng Cui, Dongyang Liu, Dongyang Liu, Dongyang Liu

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Factors Contributing to Drug Release From Enteric-Coated Omeprazole Capsules: An In Vitro and In Vivo Pharmacokinetic Study and IVIVC Evaluation in Beagle Dogs

    Factors Contributing to Drug Release From Enteric-Coated Omeprazole Capsules: An In Vitro and In Vivo Pharmacokinetic Study and IVIVC Evaluation in Beagle Dogs by Cheng Cui, Jiabei Sun, Xueqing Wang, Zhenxi Yu, Yaqin Shi

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Exposure-Response Modeling to Support Dosing Selection for Phase IIb Development of Kukoamine B in Sepsis Patients

    Exposure-Response Modeling to Support Dosing Selection for Phase IIb Development of Kukoamine B in Sepsis Patients by Huanhuan Wang, Huanhuan Wang, Huanhuan Wang, Xiaoyun Hu, Teng Wang, Teng Wang, Teng Wang, Cheng Cui, Cheng Cui, Cheng Cui, Ji Jiang, Ji Jiang, Ji Jiang, Kai Dong, Shuai Chen, Chunyan Jin, Qian Zhao, Qian Zhao, Qian Zhao, Bin Du, Pei Hu, Pei Hu, Pei Hu

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Phase I pharmacokinetic study of an oral, small-molecule MEK inhibitor tunlametinib in patients with advanced NRAS mutant melanoma

    Phase I pharmacokinetic study of an oral, small-molecule MEK inhibitor tunlametinib in patients with advanced NRAS mutant melanoma by Qian Zhao, Teng Wang, Huanhuan Wang, Cheng Cui, Wen Zhong, Diyi Fu, Wanlin Xi, Lu Si, Jun Guo, Ying Cheng, Hongqi Tian, Pei Hu

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Cytotoxicity Evaluation of Chloroquine and Hydroxychloroquine in Multiple Cell Lines and Tissues by Dynamic Imaging System and Physiologically Based Pharmacokinetic Model

    Cytotoxicity Evaluation of Chloroquine and Hydroxychloroquine in Multiple Cell Lines and Tissues by Dynamic Imaging System and Physiologically Based Pharmacokinetic Model by Jianling Yang, Zhengyang Guo, Xu Liu, Xu Liu, Qi Liu, Meng Wu, Xueting Yao, Yang Liu, Cheng Cui, Haiyan Li, Chunli Song, Dongyang Liu, Lixiang Xue

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Disruption of Mks1 localization to the mother centriole causes cilia defects and developmental malformations in Meckel-Gruber syndrome

    Disruption of Mks1 localization to the mother centriole causes cilia defects and developmental malformations in Meckel-Gruber syndrome by Cheng Cui, Bishwanath Chatterjee, Deanne Francis, Qing Yu, Jovenal T. SanAgustin, Richard Francis, Terry Tansey, Charisse Henry, Baolin Wang, Bethan Lemley, Gregory J. Pazour, Cecilia W. Lo

    Published 2011
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Dose selection of chloroquine phosphate for treatment of COVID-19 based on a physiologically based pharmacokinetic model

    Dose selection of chloroquine phosphate for treatment of COVID-19 based on a physiologically based pharmacokinetic model by Cheng Cui, Miao Zhang, Xueting Yao, Siqi Tu, Zhe Hou, Valerie Sia Jie En, Xiaoqiang Xiang, Jing Lin, Ting Cai, Ning Shen, Chunli Song, Jie Qiao, Shun Zhang, Haiyan Li, Dongyang Liu

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Development of a Physiologically Based Pharmacokinetic Model for Hydroxychloroquine and Its Application in Dose Optimization in Specific COVID-19 Patients

    Development of a Physiologically Based Pharmacokinetic Model for Hydroxychloroquine and Its Application in Dose Optimization in Specific COVID-19 Patients by Miao Zhang, Miao Zhang, Xueting Yao, Zhe Hou, Xuan Guo, Siqi Tu, Zihan Lei, Zhiheng Yu, Xuanlin Liu, Cheng Cui, Xijing Chen, Ning Shen, Chunli Song, Jie Qiao, Xiaoqiang Xiang, Haiyan Li, Haiyan Li, Dongyang Liu

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    Development of a Virtual Chinese Pediatric Population Physiological Model Targeting Specific Metabolism and Kidney Elimination Pathways

    Development of a Virtual Chinese Pediatric Population Physiological Model Targeting Specific Metabolism and Kidney Elimination Pathways by Xueting Yao, Xuanlin Liu, Xuanlin Liu, Siqi Tu, Siqi Tu, Xiaobei Li, Xiaobei Li, Zihan Lei, Zihan Lei, Zhe Hou, Zhe Hou, Zhiheng Yu, Cheng Cui, Zhongqi Dong, Farzaneh Salem, Haiyan Li, Haiyan Li, Dongyang Liu

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  10. 10
    Methanol extract of semen Ziziphi Spinosae attenuates ethanol withdrawal anxiety by improving neuropeptide signaling in the central amygdala

    Methanol extract of semen Ziziphi Spinosae attenuates ethanol withdrawal anxiety by improving neuropeptide signaling in the central amygdala by Li Bo Li, Young Woo Kim, Yu Hua Wang, Li Bai, Xiao Dong Zhu, Zheng Lin Zhao, Chul Won Lee, Yu Jiao, Tong Wu, Zhen Zhen Cai, Sang Chan Kim, Won G. An, Chae Ha Yang, Guang Cheng Cui, Rong Jie Zhao

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: